HIGHLIGHTS
- who: Alexander I. Damanakis from the DepartmentUniversity Hospital have published the article: Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma, in the Journal: Scientific Reports Scientific Reports of 24/Nov/2022
- what: The aim of this study was to analyze the expression of ITGB1 in esophageal adenocarcinoma and possibly correlate the expression profile with clinico-pathological, molecular and survival data. This study was ethically approved by the University of Cologne Ethics Committee (Reference No 13-091) and written informed consent was obtained from all patients. | Vol:.(1234567890) 12:20745 | Immunohistochemistry for Integrin beta1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.